コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 development of new synthetic methodology for radioiodination.
2 ody was also labeled using the residualizing radioiodination agent N-succinimidyl 4-guanidinomethyl-3
3 ontrast to non site-specific methods such as radioiodination, antibodies labeled with casein kinase I
5 and without a cell surface cross-linker and radioiodination in conjunction with immunoprecipitation
7 olabeling and purification for the scaled-up radioiodination of a humanized anti-carcinoembryonic ant
8 est that SIPC is a promising reagent for the radioiodination of anti-EGFRvIII L8A4 and, possibly, oth
11 e with different labeling procedures for the radioiodination of benzamides and report on initial dosi
12 that D-KRYRR is a promising reagent for the radioiodination of internalizing mAbs, such as the anti-
13 ope ([*I]SIB), which is an agent used in the radioiodination of proteins and peptides, from its tin p
17 yridinecarboxylate (SIPC) might be ideal for radioiodination of these mAbs because of the positive ch
23 The objective of this study was to develop a radioiodination procedure primarily to assess PET imagin
24 Unfortunately, cumbersome and inefficient radioiodination procedures have limited the practicality
28 potential of anti-HER2 5F7GGC Nanobody after radioiodination with the residualizing agent N-succinimi
29 thesized and conditions were established for radioiodination with yields of approximately 70% for 131